Polyclonal (pAb) and monoclonal (mAb) anti-human aorta elastin antibodies were reacted with a series of overlapping hexapeptides along the human tropoelastin sequence covering exons 2–7 and 23–36 from the N-terminus to the C-terminus, advancing 1 amino acid residue each time. ELISA indicated reactive epitopes. mAb A2.1 recognized sequences containing Ala-Lys, mAb G8.1, A7.1 and pAb, hydrophobic sequences. None of them reacted with the hexapeptide VGVAPG, or with desmosine or isodesmosine. pAb L85 reacted with a His-containing sequence coded in exon 26A. pAb *E(L), *E(S) and L85 reacted with the Cys-containing sequence of exon 36. A synthetic 14-residue peptide containing the three proximal tyrosines coded in exon 13 did not react with any of the antisera tested. It appears therefore that the most frequently recognized epitopes are hydrophobic sequences. One polyclonal antibody detected several isoforms of tropoelastin in the medium of cultured vascular smooth muscle cells. Monoclonal and polyclonal antibodies stained elastic fibers on tissue sections, suggesting that the epitopes recognized are available on the native fibers for reaction with the antibodies.

1.
Robert L, Hornebeck W: Elastin and Elastases. Boca Raton, CRC Press, 1989.
2.
Robert L, Chadwick D: The Molecular Biology and Pathology of Elastic Tissues. Ciba Foundation Symposium 192. London, Wiley, 1995.
3.
Bashir M, Indik Z, Yeh H, Abrams W, Ornstein-Goldstein N, Rosenbloom JC, Fazio M, Uitto J, Mecham R, Parks W, Rosenbloom J: Elastin gene structure and mRNA alternative splicing; in Tamburro AM, Davidson JM (eds): Elastin: Chemical and Biological Aspects. Galatina, Congedo, 1990, pp 45–70.
4.
Indik Z, Yeh H, Ornstein-Goldstein N, Sheppard P, Anderson N, Rosenbloom JC, Peltonen L, Rosenbloom J: Alternative splicing of human elastin mRNA indicated by sequence analysis of cloned genomic and complementary DNA. Proc Natl Acad Sci USA 1987;84:5680–5684.
5.
Heim RA, Pierce RA, Deak SB, Riley DJ, Boyd CD, Stolle CA: Alternative splicing of rat tropoelastin mRNA is tissue-specific and developmentally regulated. Matrix 1991;11:359–366.
6.
Robert L, Parlebas J, Poullain N, Robert B: Données nouvelles sur l’immunochimie des protéines fibreuses du tissu conjonctif; dans Peeters H (ed): Protides of the Biological Fluids. Amsterdam, Elsevier, 1963, vol 11, pp 109–113.
7.
Jackson DS, Sandberg LB, Cleary EG: Antigenic properties of soluble elastins and their use in detecting soluble elastin in ligament extracts. Nature 1966;210:195–196.
8.
Wrenn DS, Mecham RP: Immunology of elastin; in Cunningham LW (ed): Structural and Contractile Proteins. D: Extracellular Matrix. Methods Enzymol. New York, Academic Press, 1987, vol 144, pp 246–259.
9.
Wrenn DS, Griffin GL, Senior RM, Mecham RP: Characterization of biologically active domains on elastin: Identification of a monoclonal antibody to a cell recognition site. Biochemistry 1986;25:5172–5176.
10.
Marigo V, Sitta A, Volpin D, Bressan GM: Mapping of binding sites for monoclonal antibodies to chick tropoelastin by recombinant DNA techniques. Connect Tissue Res 1992;28:13–28.
11.
Robert AM, Grosgogeat Y, Reverdy V, Robert B, Robert L: Lésions artérielles produites chez le lapin par immunisation avec l’élastine et les glycoprotéines de structure de l’aorte. Etudes biochimiques et morphologiques. Atherosclerosis 1971;13:427–449.
12.
Jacob MP, Hornebeck W, Lafuma C, Bernaudin JF, Robert L, Godeau G: Ultrastructural and biochemical modifications of rabbit arteries induced by immunization with soluble elastin peptides, Exp Mol Pathol 1984;41:171–190.
13.
Stein F, Pezess MP, Robert L, Poullain N: Anti-elastin antibodies in normal and pathological human sera. Nature 1965;207:312–313.
14.
Horsch AK, Bréchemier D, Robert L, Horsch S: Anti-Elastin Antikörper bei der Thrombangiitis obliterans. Verh Dtsch Ges Inn Med 1977;83:1757–1762.
15.
Bako G, Jacob MP, Fülöp T, Foris G, Leövey A, Robert L: Immunology of elastin: Study of anti-elastin peptide antibodies by DOT immunobinding assay. Immunol Lett 1987;15:187–192.
16.
Fülöp T, Jacob MP, Robert L: Determination of anti-elastin peptide antibodies in normal and arteriosclerotic human sera by Elisa. J Clin Lab Immunol 1989;30:69–74.
17.
Robert L, Jacob MP, Frances C, Godeau G, Hornebeck W: Interaction between elastin and elastases and its role in the aging of the arterial wall, skin and other connective tissues. A review. Mech Ageing Dev 1984;28:155–166.
18.
Fülöp T Jr, Wei SM, Robert L, Jacob MP: Determination of elastin peptides in normal and arteriosclerotic human sera by ELISA. Clin Physiol Biochem 1990;8:273–282.
19.
Kucich U, Christner P, Lippmann M, Fein A, Goldberg A, Kimbel P, Weinbaum G, Rosenbloom J: Immunologic measurement of elastin-derived peptides in human serum. Am Rev Respir Dis 1983;127:-S28–S30.
20.
Darnule TV, MacKee M, Darnule AT, Turino GM, Mandl I: Solid-phase radioimmunoassay for estimation of elastin peptides in human sera. Anal Biochem 1982;122:302–307.
21.
Wei SM, Erdei J, Fülöp T Jr, Robert L, Jacob MP: Elastin peptide concentration in human serum: Variation with antibody and elastin peptides used for the enzyme-linked immunosorbent assay. J Immunol Methods 1993;164:175–187.
22.
Harel S, Janoff A, Yu SY, Hurewitz A, Bergofsky EH: Desmosine radioimmunoassay for measuring elastin degradation in vivo. Am Rev Respir Dis 1980;122:769–773.
23.
Skinner SJM, Schellenberg JC, Liggins GC: The estimation of elastin in fetal tissues by radioimmunoassay of isodesmosine. Connect Tissue Res 1983;11:113–121.
24.
Geysen HM, Meloen RH, Barteling SJ: Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci USA 1984;81:3998–4002.
25.
Schoofs PG, Geysen HM, Jackson DC, Brown LE, Tang XL, White DO: Epitopes of an influenze viral peptide recognized by antibody at single amino acid resolution. J Immunol 1988;140:611–616.
26.
Brown PL, Mecham L, Tisdale C, Mecham RP: The cysteine residues in the carboxy terminal domain of tropoelastin form an intrachain disulfide bond that stabilizes a loop structure and positively charged pocket. Biochem Biophys Res Commun 1992;186:549–555.
27.
Debelle L, Wei SM, Jacob MP, Hornebeck W, Alix AJP: Predictions of the secondary structure and antigenicity of human and bovine tropoelastins, Eur Biophys J 1992;21:321–329.
28.
Jacob MP, Hornebeck W: Isolation and characterization of insoluble and kappa-elastins; in Robert L (ed): Methods of connective tissue research. Front Matrix Biol. Basel, Karger, 1985, vol 10, pp 92–129.
29.
Hornebeck W, Soleilhac JM, Tixier JM, Moczar E, Robert L: Inhibition by elastase inhibitors of the formyl-Met-Leu-Phe-induced chemotaxis of rat polymorphonuclear leukocytes. Cell Biochem Funct 1987;5:113–122.
30.
Stahli C, Staehelin T, Miggiano V, Schmidt J, Haring P: High frequencies of antigen-specific hybridomas: Dependence on immunization parameters and prediction by spleen cell analysis. J Immunol Methods 1980;32:297–309.
31.
Köhler G, Milstein C: Continuous cultures of fused cells secreting antibody with predefined specificity. Nature 1975;256:495–506.
32.
Erickson BM, Merrifield RB: Solid phase peptide synthesis; in Neurath H, Hill RL (eds): The Proteins. New York, Academic Press, 1996, vol 2, pp 255–527.
33.
Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some application. Proc Natl Acad Sci USA 1979;76:4350–4354.
34.
Raju K, Anwar RA: Primary structures of bovine elastin a, b, and c deduced from the sequences of cDNA clones. J Biol Chem 1987;262:5755–5762.
35.
Gerber GE, Anwar RA: Comparative studies of the cross-linked regions of elastin from bovine ligamentum nuchea and bovine, porcine and human aorta. Biochem J 1975;149:685–695.
36.
Senior RM, Griffin GL, Mecham RP, Wrenn DS, Prasad KU, Urry DW: Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin is chemotactic for fibroblasts and monocytes. J Cell Biol 1984;99:870–874.
37.
Kagan HM, Williams MA, Williamson PR, Anderson JM: Influence of sequence and charge on the specificity of lysyloxidase toward protein and synthetic peptide substrates. J Biol Chem 1984;259:11203–11207.
38.
Jacob MP: L’élastine: préparation, caractérisation, structure, biosynthèse et catabolisme. CR Soc Biol 1993;187:166–180.
39.
Rosenbloom J, Weinbaum G, Abrams W, Ornstein-Goldstein N, Indik Z, Kucich U: Newly determined carboxy-terminal sequences in tropoelastin: Immunologic identification in insoluble elastin. Coll Relat Res 1986;6:423–433.
40.
Machebœuf M, Robert B: Etudes sur la dénaturation des protéines. I. Autooxydation des protéines en milieu alcalin. Bull Soc Chim Biol 1953;35:399–411.
41.
Godeau G: Selective staining technique for identification of human skin elastic fibers. Pathol Biol 1984;32:215–216.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.